FdaApplication
BLA 761074
Identifiers
- fda_app_no: BLA761074
Properties
| Property | Value |
|---|---|
| applicant_name | Biocon Biologics Inc. |
| application_type | BLA |
| approval_date | 2017-12-01 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OGIVRI | TRASTUZUMAB-DKST | 420MG | For Injection |
| OGIVRI | — | 150MG | For Injection |
2 products